Dr Peter M Daher, MD | |
Burgess Health Center, 1600 Diamond Ave, Onawa, IA 51040-5104 | |
(712) 423-2311 | |
Not Available |
Full Name | Dr Peter M Daher |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | Burgess Health Center, Onawa, Iowa |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528053006 | NPI | - | NPPES |
9685 | Other | NE | MIDLANDS CHOICE |
0106035 | Other | NE | AMERICHOICE |
30105 GRP: 7553 | Other | NE | BCBS |
47-075591500 | Medicaid | NE | |
8967893 | Medicaid | IA | |
P00312875 GRP CK4096 | Other | NE | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 19356 (Nebraska) | Secondary |
207P00000X | Emergency Medicine | 19356 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Peter M Daher, MD 11753 Pacific St, Omaha, NE 68154-3444 Ph: (402) 290-1212 | Dr Peter M Daher, MD Burgess Health Center, 1600 Diamond Ave, Onawa, IA 51040-5104 Ph: (712) 423-2311 |
News Archive
A team of scientists led by Associate Professor Zeng Qi from A*STAR's Institute of Molecular and Cell Biology (IMCB) have discovered a new biomarker which will help physicians predict how well cancer patients respond to cancer drugs.
National Health Partners, Inc. (OTCBB: NHPR), a leading provider of unique discount healthcare membership programs, announced that it expects to generate positive cash flows from operating activities of almost $100,000 during August, representing the first time in the company's history that it has achieved positive cash flows from operating activities for a full month.
Boron-neutron capture therapy (BNCT) is an experimental treatment for virulent brain cancer that aims to kill malignant cells by generating high-energy alpha particles inside tumors.
GE Capital, Healthcare Financial Services today announced it has provided an $11.25 million credit facility to Pacira Pharmaceuticals, Inc. The financing provides working capital, and facilitates advances toward regulatory approval and preparation for commercialization of Pacira's EXPARELâ„¢ program.
Older people who were newly diagnosed with depression had a slower walking speed and a shorter step length compared with those without depression in a recent Journal of the American Geriatrics Society study.
› Verified 3 days ago